The Impact of Antimicrobial‐Resistant, Health Care–Associated Infections on Mortality in the United States | Zendy

R. Monina Klevens | Zendy; Jonathan R. Edwards | Zendy; R. P. Gaynes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Impact of Antimicrobial‐Resistant, Health Care–Associated Infections on Mortality in the United States

Author(s) -

R. Monina Klevens,

Jonathan R. Edwards,

R. P. Gaynes

Publication year - 2008

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/591698

Subject(s) - medicine , antimicrobial , pseudomonas aeruginosa , staphylococcus aureus , pneumonia , intensive care medicine , microbiology and biotechnology , bacteria , biology , genetics

We used data reported from US hospitals to the National Nosocomial Infection Surveillance System of the Centers for Disease Control and Prevention for 3 specific infections: Staphylococcus aureus bloodstream infections, Pseudomonas aeruginosa pneumonias, and Escherichia coli urinary tract infections. We evaluated the proportion of infections with antimicrobial-resistant isolates and the relative risk of death associated with the resistant pathogen in the period 2000-2004, compared with the period 1990-1994. The proportion of antimicrobial-resistant infections increased, but there was no change in the relative risk of death between the 2 periods.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research